Servier Drug Risk Trial Suspended After Challenge, France 3 Says

Les Laboratoires Servier and its founder won their bid to suspend a trial over claims they hid the risks of a diabetes drug, when a judge ruled their constitutional challenge to the process was serious enough to merit a higher court’s review, France 3 reported today, citing the judge.

A procedural hearing is planned for Dec. 14 to reschedule the trial, pending the outcome of the constitutional review, France 3 said on its website.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE